Neurology CRO

Understanding Leqembi: The Latest Advancement in Alzheimer’s Disease Therapy

Understanding Leqembi: The Latest Advancement in Alzheimer’s Disease Therapy

Leave a Comment / Articles /

Alzheimer’s Disease (AD) is the most common type of dementia and is characterized by changes in the brain. While the specific causes of Alzheimer’s are not fully known, the changes include senile plaques composed of amyloid β protein (Aβ) and neurofibrillary, or tau, tangles. Resulting in a loss of neurons and their connections, these changes […]

Understanding Leqembi: The Latest Advancement in Alzheimer’s Disease Therapy Read More »

Enhancing Caregiver Support: The Key to Advancing Neurodegenerative Disease Clinical Trials

Enhancing Caregiver Support: The Key to Advancing Neurodegenerative Disease Clinical Trials

Leave a Comment / Articles /

Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s Disease are devastating illnesses that collectively affect millions of people worldwide. As these diseases progress, patients often require increasing levels of care and support from their caregivers. For this reason, one of the common recruitment and retention challenges faced within neurodegenerative disease clinical trials is that these

Enhancing Caregiver Support: The Key to Advancing Neurodegenerative Disease Clinical Trials Read More »

Inside a state-of-the-art medical laboratory, a male scientist intently types on his keyboard while focused on his work.

The Most Innovative Neurology Startups in Biotech: Meet the Game-Changers Who are Reshaping the Future of Brain Research

Leave a Comment / Articles /

Advancements in neuroscience research and technology are paving the way for groundbreaking developments in the field of neurology. At the 2022 Precision Neuroscience Summit, scientists and industry experts predicted a wave of system-level innovation in neurology by 2030, driving accelerated research and development (R&D) in precision neuroscience. This article highlights five innovative neurology startups in

The Most Innovative Neurology Startups in Biotech: Meet the Game-Changers Who are Reshaping the Future of Brain Research Read More »

A compassionate male nurse assists a senior man in a wheelchair.

Innovations in ALS Research: Clinical Trials for Emerging Therapies

Leave a Comment / Articles /

Amyotrophic lateral sclerosis (ALS) is a progressive fatal neurodegenerative condition that causes a gradual loss of motor neurons in the brain and results in patients slowly losing their motor control. Despite the challenging nature of drug development for neurological diseases and rare diseases, the landscape of ALS research has expanded significantly over the last decade.

Innovations in ALS Research: Clinical Trials for Emerging Therapies Read More »

The Future of Neurology: Exciting Developments in the Treatment of Nervous System Disorders

The Future of Neurology: Exciting Developments in the Treatment of Nervous System Disorders

Leave a Comment / Articles /

Neurological disorders are the second leading cause of death and the leading cause of disability worldwide. According to a global burden of disease study, neurological disorders with the highest burden in the U.S. include stroke, Alzheimer’s disease (AD) and other dementias, and migraine. The Centers for Disease Control and Prevention (CDC) indicate that stroke is

The Future of Neurology: Exciting Developments in the Treatment of Nervous System Disorders Read More »

An image of brain scans to represent care within Huntington's Disease clinical trials.

Huntington’s Disease Clinical Trials: Opportunities and Challenges for Biotech and Pharma Sponsors

Leave a Comment / Articles /

Huntington’s disease (HD) is a rare disease, an inherited monogenic neurodegenerative and ultimately fatal disease with no disease-modifying interventions. It manifests typically in mid-life with progressive motor, cognitive, and behavioral dysfunction seriously eroding quality of life. Two factors provide substantial power for clinical studies evaluating disease progression or potential modification by treatment, namely 1) HD

Huntington’s Disease Clinical Trials: Opportunities and Challenges for Biotech and Pharma Sponsors Read More »

Vial Announces the Addition of Dr. Egilius L.H. Spierings of MedVadis Research Corporation to their Central Nervous System Scientific Advisory Board

Vial Announces the Addition of Dr. Egilius L.H. Spierings of MedVadis Research Corporation to their Central Nervous System Scientific Advisory Board

Leave a Comment / Press Releases /

San Francisco, CA. March 8, 2022 — Vial, a global tech-first CRO providing next-generation clinical trial management services, announced the addition of Egilius L.H. Spierings, MD, Ph.D., to Vial’s central nervous system (CNS) scientific advisory board (SAB). Dr. Spierings will work closely with the company’s leadership team to shape the scientific strategy of Vial’s Neurology

Vial Announces the Addition of Dr. Egilius L.H. Spierings of MedVadis Research Corporation to their Central Nervous System Scientific Advisory Board Read More »

Dr. Goadsby joins Vial's Neurology CRO Scientific Advisory Board.

Dr. Peter Goadsby of the NIHR Wellcome Trust at the King’s College Clinical Research Facility, London, Joins Vial’s Neurology CRO as a Scientific Advisor

Leave a Comment / Press Releases /

San Francisco, CA. December 14, 2022 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, welcomes Dr. Peter Goadsby as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Goadsby is the Director of the NIHR Wellcome Trust at the King’s College Clinical Research Facility, London, and a Professor of Neurology at

Dr. Peter Goadsby of the NIHR Wellcome Trust at the King’s College Clinical Research Facility, London, Joins Vial’s Neurology CRO as a Scientific Advisor Read More »

CRO

Resources

Company

Sign up for Newsletter

By submitting, you are agreeing to our terms and privacy policy

© 2024 Vial. All rights reserved